BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26169281)

  • 1. Evaluation of inter- and intrafractional motion of liver tumors using interstitial markers and implantable electromagnetic radiotransmitters in the context of image-guided radiotherapy (IGRT) - the ESMERALDA trial.
    Habermehl D; Naumann P; Bendl R; Oelfke U; Nill S; Debus J; Combs SE
    Radiat Oncol; 2015 Jul; 10():143. PubMed ID: 26169281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy.
    Habermehl D; Henkner K; Ecker S; Jäkel O; Debus J; Combs SE
    J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i61-8. PubMed ID: 23824129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor motion changes in stereotactic body radiotherapy for liver tumors: an evaluation based on four-dimensional cone-beam computed tomography and fiducial markers.
    Shimohigashi Y; Toya R; Saito T; Ikeda O; Maruyama M; Yonemura K; Nakaguchi Y; Kai Y; Yamashita Y; Oya N; Araki F
    Radiat Oncol; 2017 Mar; 12(1):61. PubMed ID: 28335794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive inter- and intrafractional motion control in ultrahypofractionated radiation therapy of prostate cancer using RayPilot HypoCath™-a substitute for gold fiducial-based IGRT?
    Berchtold J; Winkler C; Karner J; Groher M; Gaisberger C; Sedlmayer F; Wolf F
    Strahlenther Onkol; 2024 Mar; 200(3):195-201. PubMed ID: 37626226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric implications of inter- and intrafractional prostate positioning errors during tomotherapy : Comparison of gold marker-based registrations with native MVCT.
    Wust P; Joswig M; Graf R; Böhmer D; Beck M; Barelkowski T; Budach V; Ghadjar P
    Strahlenther Onkol; 2017 Sep; 193(9):700-706. PubMed ID: 28466155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To frame or not to frame? Cone-beam CT-based analysis of head immobilization devices specific to linac-based stereotactic radiosurgery and radiotherapy.
    Babic S; Lee Y; Ruschin M; Lochray F; Lightstone A; Atenafu E; Phan N; Mainprize T; Tsao M; Soliman H; Sahgal A
    J Appl Clin Med Phys; 2018 Mar; 19(2):111-120. PubMed ID: 29363282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Feasibility and Efficiency of Volumetric Modulated Arc Therapy-Based Breath Control Stereotactic Body Radiotherapy for Liver Tumors.
    Qiu JJ; Ge W; Zhang L; Yao Y; Zheng X
    Technol Cancer Res Treat; 2016 Oct; 15(5):674-82. PubMed ID: 26206766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring.
    Lee YYD; Nguyen DT; Moodie T; O'Brien R; McMaster A; Hickey A; Pritchard N; Poulsen P; Tabaksblat EM; Weber B; Worm E; Pryor D; Chu J; Hardcastle N; Booth J; Gebski V; Wang T; Keall P
    BMC Cancer; 2021 May; 21(1):494. PubMed ID: 33941111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of inter- and intra fractional partial bladder wall movement using implanted fiducial markers.
    Nishioka K; Shimizu S; Shinohara N; Ito YM; Abe T; Maruyama S; Katoh N; Kinoshita R; Hashimoto T; Miyamoto N; Onimaru R; Shirato H
    Radiat Oncol; 2017 Mar; 12(1):44. PubMed ID: 28249609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential failure risk of the cone-beam computed tomography-based planning target volume margin definition for prostate image-guided radiotherapy based on a prospective single-institutional hybrid analysis.
    Hirose K; Sato M; Hatayama Y; Kawaguchi H; Komai F; Sohma M; Obara H; Suzuki M; Tanaka M; Fujioka I; Ichise K; Takai Y; Aoki M
    Radiat Oncol; 2018 Jun; 13(1):106. PubMed ID: 29880006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adequacy of inhale/exhale breathhold CT based ITV margins and image-guided registration for free-breathing pancreas and liver SBRT.
    Yang W; Fraass BA; Reznik R; Nissen N; Lo S; Jamil LH; Gupta K; Sandler H; Tuli R
    Radiat Oncol; 2014 Jan; 9():11. PubMed ID: 24401365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance.
    Sveistrup J; af Rosenschöld PM; Deasy JO; Oh JH; Pommer T; Petersen PM; Engelholm SA
    Radiat Oncol; 2014 Feb; 9():44. PubMed ID: 24495815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Image-guided radiotherapy for liver cancer using respiratory-correlated computed tomography and cone-beam computed tomography.
    Guckenberger M; Sweeney RA; Wilbert J; Krieger T; Richter A; Baier K; Mueller G; Sauer O; Flentje M
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):297-304. PubMed ID: 18406894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic intrafractional position monitoring with implanted fiducial markers for enhanced accuracy in radiotherapy of prostate cancer.
    Mangesius J; Seppi T; Ibrahim R; Fleischmann K; Ginestet A; Vorbach S; Hart T; Pointner M; Mangesius S; Ganswindt U
    Phys Eng Sci Med; 2023 Dec; 46(4):1365-1374. PubMed ID: 37523057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implementation of an online adaptive plan-of-the-day protocol for nonrigid motion management in locally advanced cervical cancer IMRT.
    Heijkoop ST; Langerak TR; Quint S; Bondar L; Mens JW; Heijmen BJ; Hoogeman MS
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):673-9. PubMed ID: 25151538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a Device-Free Compressed Shell Fixation Method on Hepatic Respiratory Movement: Analysis for Respiratory Amplitude of the Liver and Internal Motions of a Fiducial Marker.
    Hashimoto S; Katsurada M; Muramatsu R; Asai K; Tanaka K; Hayashi K; Kibe Y; Nakajima K; Hattori Y; Iwata H; Mizoe JE; Ogino H; Shibamoto Y
    Pract Radiat Oncol; 2019 Mar; 9(2):e149-e155. PubMed ID: 30336269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
    Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
    Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients.
    Böckelmann F; Putz F; Kallis K; Lettmaier S; Fietkau R; Bert C
    Strahlenther Onkol; 2020 Jul; 196(7):647-656. PubMed ID: 32157345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR-guidance--a clinical study to evaluate a shuttle- based MR-linac connection to provide MR-guided radiotherapy.
    Bostel T; Nicolay NH; Grossmann JG; Mohr A; Delorme S; Echner G; Häring P; Debus J; Sterzing F
    Radiat Oncol; 2014 Jan; 9():12. PubMed ID: 24401489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markers.
    Oehler C; Lang S; Dimmerling P; Bolesch C; Kloeck S; Tini A; Glanzmann C; Najafi Y; Studer G; Zwahlen DR
    Radiat Oncol; 2014 Nov; 9():229. PubMed ID: 25384898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.